O
Orca Bio
Developing high-precision allogeneic cell therapies designed to safely replace patients’ diseased blood and immune system with a healthy one
About Orca Bio
Orca Bio is a biotechnology startup that operates in the cell therapy market. The company's primary focus is to enhance the benefits of cell therapies, which are treatments that use the body's own cells to fight diseases. These therapies have the potential to revolutionize healthcare, particularly for conditions that currently lack effective treatments. Orca Bio aims to improve these therapies by making them safer and more effective, thereby delivering better outcomes for patients.
Read full description
The company's clients are primarily healthcare providers and patients. Healthcare providers may use Orca Bio's therapies to treat their patients, while patients may receive these therapies as part of their treatment plans. Orca Bio's business model revolves around the research, development, and commercialization of its cell therapies. The company makes money by selling these therapies to healthcare providers.
Orca Bio is also dedicated to fostering a strong team culture. The company values its employees and is always looking for talented individuals to join its team. It also prioritizes keeping its stakeholders informed about its latest developments, as evidenced by its regularly updated newsroom.
In summary, Orca Bio is a promising startup in the cell therapy market. Its focus on improving cell therapies could have a significant impact on healthcare, making it a company to watch in the biotechnology sector.
At a glance
- Founded
- 2016
- Headquarters
- Menlo Park, United States
- Sector
- Biotech & Life Sciences
- Power Law
- Unicorn$1–10B valuation tier
Latest news
Press, funding announcements and product moves mentioning Orca Bio.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed2 investors entered at this stage
Series A1 investor entered at this stage
Series B and later6 investors entered at this stage
+ND Capital
Kaiser Permanente
IMRF
8VC
Mubadala Capital
Silicon Valley Bank
Source: Dealroom Talent Intelligence.
Global footprint
team presence
across markets
Patents
8 active patent families included in this estimate.
A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.
Market sentiment
An AI-synthesised read of the highest-engagement posts about Orca Bio on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Orca Bio on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.